ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: TH-PO780

Validation of the Novel "Race Free" CKD-EPI Equation in Persons Aged 70 and Older: The Berlin Initiative Study

Session Information

Category: Geriatric Nephrology

  • 1200 Geriatric Nephrology


  • Ebert, Natalie, Charite Universitatsmedizin Berlin, Berlin, Berlin, Germany
  • Pottel, Hans, KULeuven University, Kortrijk, Belgium
  • Delanaye, Pierre, Sart Tilman University, Liège, Belgium
  • van der Giet, Markus, Charite Universitatsmedizin Berlin, Berlin, Berlin, Germany
  • Kuhlmann, Martin K., Vivantes Klinikum im Friedrichshain, Berlin, Berlin, Germany
  • Schaeffner, Elke, Charite Universitatsmedizin Berlin, Berlin, Berlin, Germany

The creatinine-based CKD-EPI (ASR) equation from 2009 (ASR: age, sex, and race) has been replaced by the CKD-EPI (AS) equation using the same mathematical form without the race variable because the former has been considered a source of discrimination. NKF recently recommended using the "race free“ CKD-EPI (AS) equation for patients in the US. It is unclear whether this is favorable for older patients. Our study compares the performance of CKD-EPI (AS), CKD-EPI (ASR), and the European Kidney Function Consortium (EKFC) equation.


We analyzed data from 570 participants of the "Berlin Initiative Study“ (BIS), a community-dwelling cohort of white older adults. We measured GFR (mGFR) with iohexol plasma clearance as gold standard. We calculated bias as estimated GFR (eGFR) minus mGFR, precision (interquartile range, IQR), and accuracy (P30: percentage of eGFR values within +/- 30% mGFR). CKD-EPI (ASR), CKD-EPI (AS) and EKFC equations were validated using mGFR.


Mean age was 78.5 yrs, 57% were male, and mean mGFR was 60.3 ml/min/1.73m2. Mean Bias for CKD-EPI (AS) was highest with 13.0 compared to 8.4 and 1.6 ml/min/1.73m2 for CKD-EPI (ASR) and EKFC (Tbl. 1). P30 value was lowest for CKD-EPI (AS) (67%) compared to CKD-EPI (ASR, 81%) and EKFC (92%). Stratified by age (≥80 yrs) and mGFR (mGFR <60), we found even worse P30 results for CKD-EPI (AS) with 58% and 52% (Fig. 1).


In the US, the novel "race-free“ CKD-EPI (AS) equation is recommended for diagnosing CKD. Our results suggest that CKD-EPI (AS) leads to a considerable systematic overestimation and worse prediction of eGFR in older patients. In pts. with GFR <60, P30 was even worse with only 52%, enhancing the risk of drug overdosing and delayed CKD diagnosis.


  • Private Foundation Support